Testosterone, or low T. No matter what you call it, it’s time to debunk the myth that testosterone therapy for men with low T increases prostate cancer risk. It all began over 80 years ago. “In 1941 Huggins and Hodges reported that marked reductions in T by castration or estrogen treatment caused metastatic [prostate cancer keep reading

Check out the name of this type of prostate imaging: microultrasonography. It’s a mouthful, and if you have trouble pronouncing it, you’re not alone. Let me break it down: Micro = very small. You may know words like micrometer or micromanage, same idea. Ultrasono = ultrasound. Graphy = graphics. Put it all together and it keep reading

Today’s multiparametric MRI (mpMRI) has revolutionized the prostate cancer (PCa) world. Thanks to its high resolution, 3-dimensional imaging done by a powerful 3 Tesla (3T) magnet, experienced radiologists are able to identify areas that are suspicious for clinically significant PCa (csPCa). This helps avoid unnecessary biopsies, but if a biopsy is indicated, the area can keep reading

How times and technology change! Take, for example, the shift from a tangible book like the Yellow Pages to a digital one. At one time, paper copies of the Yellow Pages business directory were delivered to virtually every household in America. This hefty local book was the ultimate resource for finding a business or service keep reading

Today’s multiparametric MRI (mpMRI) is better than ever. When a patient’s PSA blood test raises suspicion of prostate cancer (PCa), mpMRI determines if a targeted biopsy is needed. It does this by making significant lesions visible prior to an invasive biopsy. Significant means Gleason 3+4 or greater, also characterized as Grade Group 2 or greater. keep reading

A new paper on PSA screening for prostate cancer (PCa) begins by pointing out that screening reduces PCa deaths; however, PSA followed by immediate biopsy increases cases of low-risk patients who have overly aggressive treatments that leave them with impaired urinary or sexual function—up to 12 years or more![i] The authors propose more refined screening keep reading

“What treatment do most patients choose?” Occasionally I’m asked this question, so I thought it would be interesting to present some statistics from published studies. 2011 data (low risk PCa) I’ll start with data presented in a 2011 article by a British team.[i] The authors collected records on 768 of their center’s patients with early keep reading

When you get out of bed in the morning, no one hands you a script for how your day will go. Most days, you can expect the day will proceed as planned, and it’s reasonable to believe you can meet surprise changes in routine without being thrown off balance. Sometimes, however, the surprise is unpleasant. keep reading

If Sherlock Holmes was a real person, would he be able to solve the mysterious case of chemical exposure and prostate cancer? Specifically, I’m talking about the chemicals used in products that kill bugs. Can you see where I’m going with this? If some chemicals are harmful to living cells in insects, might they also keep reading

In 2020, an editorial in a medical journal observed, “As the Internet is now an established platform and easily accessible, patients are increasingly seeking information from websites out of curiosity and for additional questions pertaining to their health condition.”[i] Well, sure. What could be more efficient than sitting in front of your home or office keep reading